Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction

Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction

US Patent 6162432 · Granted Dec 19, 2000

Estimated economic value: $152,049,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vitamin D as an immune modulator to prevent immune-related complication from COV2024
Biomarkers for human monocyte myeloid-derived suppresor cells2019
Methods of detecting cancer2018
Methods of generating hyper INOS expressing cells and uses thereof2016
Salts of isophosphoramide mustard and analogs thereof2016
Photodynamic therapy including light pretreatment2015
Methods and reagents for identifying/isolating T regulatory (Treg) cells and for2014
Method for controlling angiogenesis in animals2014
Methods of generating hyper iNOS expressing cells and uses thereof2014
Salts of isophosphoramide mustard and analogs thereof2013
Combination therapy with organic arsenicals2012
Topical delivery of phthalocyanines2012